v1 Print

1
1 OPENING CASH AND BANK BALANCES 3,268 413 1,473 -2,462 -2,232 -662 -6,652 413 RECEIPTS 13,446 5,000 1,900 4,200 4,500 4,000 3,900 Sales Local loans Group loans and share capital Deposit returned and securities sold Import deposits Other receipts (give details) Comision 267 430 0 250 0 0 250 2 Total Receipts 13,713 5,430 1,900 4,450 4,500 4,000 4,150 24,430 PAYMENTS Wages, salarios and related staff coste 2,446 1,000 605 1,100 650 650 1,100 Purchases and expenses 9,911 2,600 4,600 2,500 1,900 9,000 1,250 Customs and import dutles Capital expenditure Taxation 375 280 160 110 0 0 120 Interest on borrowings 167 140 0 160 0 0 160 Loan repaments Deposit placed and securities purchased Import deposits Other payments (give details) Advanced from Indemnization 205 0 70 0 0 0 0 Advanced to employees 57 0 0 0 0 0 0 Inter-company payments Other expenses 3,407 350 400 350 380 340 400 Goods account, Glaxo Group Ltd Other Group companies (Analyse on separato sheet) Loan account, Glaxo Ltd. Other Group companies (Analyse on separato sheet) 3 Total Payments 16,568 4,370 5,835 4,220 2,930 9,990 3,030 30,375 4 CLOSING CASH AND BANK BALANCES = (1+2-3) 413 1,473 -2,462 -2,232 -662 -6,652 -5,532 -5,532 5 Other realisable deposits or securities 2,462 2,000 662 6,652 5,532 6 Unitilised loans or credit facilities 232 7 TOTAL POSIBLE LIQUID RESOURSE (4-5-6) 413 1,473 0 0 0 0 0 -5,532 CASH FORECAST (FORM 605) (000') en miles de soles Septiembre Total FORECAST For Six Mon as To Septiembre Company: Laboratorio Glaxo Del Peru S.A. Date (quarter ending): Septiembre Currency: Nuevos Soles ACTUAL Last Six Months Abril Mayo Junio Julio Agosto

description

v1 Print

Transcript of v1 Print

  • 1 OPENING CASH AND BANK BALANCES 3,268 413 1,473 -2,462 -2,232 -662 -6,652 413

    RECEIPTS 13,446 5,000 1,900 4,200 4,500 4,000 3,900Sales

    Local loans

    Group loans and share capital

    Deposit returned and securities sold

    Import deposits

    Other receipts (give details)

    Comision 267 430 0 250 0 0 250

    2 Total Receipts 13,713 5,430 1,900 4,450 4,500 4,000 4,150 24,430

    PAYMENTS

    Wages, salarios and related staff coste 2,446 1,000 605 1,100 650 650 1,100Purchases and expenses 9,911 2,600 4,600 2,500 1,900 9,000 1,250Customs and import dutles

    Capital expenditure

    Taxation 375 280 160 110 0 0 120Interest on borrowings 167 140 0 160 0 0 160Loan repaments

    Deposit placed and securities purchased

    Import deposits

    Other payments (give details)

    Advanced from Indemnization 205 0 70 0 0 0 0Advanced to employees 57 0 0 0 0 0 0Inter-company payments

    Other expenses 3,407 350 400 350 380 340 400Goods account, Glaxo Group Ltd

    Other Group companies (Analyse on separato sheet)

    Loan account, Glaxo Ltd.

    Other Group companies (Analyse on separato sheet)

    3 Total Payments 16,568 4,370 5,835 4,220 2,930 9,990 3,030 30,375

    4 CLOSING CASH AND BANK BALANCES = (1+2-3) 413 1,473 -2,462 -2,232 -662 -6,652 -5,532 -5,532

    5 Other realisable deposits or securities 2,462 2,000 662 6,652 5,532

    6 Unitilised loans or credit facilities 232

    7 TOTAL POSIBLE LIQUID RESOURSE (4-5-6) 413 1,473 0 0 0 0 0 -5,532

    CASH FORECAST (FORM 605) (000') en miles de soles

    Septiembre Total

    FORECAST For Six Mon as To Septiembre

    Company: Laboratorio Glaxo Del Peru S.A. Date (quarter ending): Septiembre Currency: Nuevos Soles

    ACTUAL Last Six

    Months Abril Mayo Junio Julio Agosto